Transfersomes: A novel vesicular carrier for enhanced transdermal delivery of sertraline: Development, characterization, and performance evaluation

Scientia Pharmaceutica

Volumn 80, Issue 4, 2012, Pages 1061-1080

  Gupta, Ankit ^a   Aggarwal, Geeta ^b   Singla, Samita ^b   Arora, Ritika ^b  

^a Rayat Institute of Pharmacy   (India)

^b INSTITUTE OF NANO SCIENCE AND TECHNOLOGY   (India)

Author keywords

In vivo study; Permeation studies; Sertraline; Transdermal; Transfersomes

Indexed keywords

CARBOPOL 940; CELLOPHANE; DRUG CARRIER; NONIONIC SURFACTANT; PHOSPHATIDYLCHOLINE; SERTRALINE; SORBITAN OLEATE; TRANSFERSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; EXCIPIENT; FEMALE; FLOW KINETICS; FORCED SWIMMING TEST; GUINEA PIG; INFRARED SPECTROSCOPY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PERMEABILITY; PHYSICAL PARAMETERS; RAT; SKIN IRRITATION; TRANSMISSION ELECTRON MICROSCOPY; TURBIDITY; ULTRAVIOLET SPECTROPHOTOMETRY; VISCOSITY;

EID: 84870947677     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1208-02     Document Type: Article

References (22)

1. Kilts CD. Potential New Drug Delivery Systems for Antidepressants: An overview. J Clin Psychiatry. 2003; 64: 31-33. http://www.ncbi.nlm.nih.gov/pubmed/14700453
2. Kim A, Lee EH, Choi SH, Kim CK. In vitro and in vivo transfection efficiency of a novel ultra deformable cationic polymer. Biomatetrials. 2004; 25: 305-313. http://dx.doi.org/10.1016/S0142-9612(03)00534-9
3. Vijaya R, Ruckmani K. In vitro and In vivo characterization of the transdermal delivery of sertraline hydrochloride Films. Daru. 2011; 19: 424-432. http://www.ncbi.nlm.nih.gov/pubmed/23008688
4. Jain S, Jain P, Umamaheshwari RB, Jain NK. Transfersomes-A novel vesicular carrier for enhanced transdermal delivery: Development, characterization and performance evaluation. Drug Dev Ind Pharm. 2003; 29: 1013-1026. http://dx.doi.org/10.1081/DDC-120025458
5. Mishra D, Garg M, Dubey V, Jain S, Jain NK. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: Propranolol hydrochloride. J Pharm Sci. 2007; 96: 145-155. http://dx.doi.org/10.1002/jps.20737
6. Garg T, Jain S, Singh HP, Sharma A, Tiwary AK. Elastic liposomal formulation for sustained delivery of antimigraine drug: in vitro characterization and biological evaluation. Drug Dev Ind. Pharm. 2008; 34: 1100-1110. http://www.ncbi.nlm.nih.gov/pubmed/18663655
7. Layek B, Mukherjee B. Tamoxifen Citrate Encapsulated Sustained Release Liposomes: Preparation and Evaluation of Physicochemical Properties. Sci Pharm. 2010; 78: 507-515. http://dx.doi.org/10.3797/scipharm.0911-11
8. El-Maghraby GMM, Williams AC, Barry BW. Skin delivery of 5-Fluorouracil from ultra deformable and traditional liposomes in vitro. J Pharm Pharmacol. 2001; 53: 1069-1076. http://dx.doi.org/10.1211/0022357011776450
9. Malakar J, Sen SO, Nayak AK, Sen KK. Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi Pharm J. 2012; 20: 355-363. http://dx.doi.org/10.1016/j.jsps.2012.02.001
10. Guo J, Ping Q, Sun G, Jiao C. Lecithin vesicular carriers for transdermal delivery of cyclosporine A. Int J Pharm. 2000; 194: 201-207. http://dx.doi.org/10.1016/S0378-5173(99)00361-0
11. Patel MR, Patel RB, Parikh JR, Solanki AB, Patel BG. Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole. AAPS PharmSciTech. 2009; 10: 917-923. http://dx.doi.org/10.1208/s12249-009-9286-2
12. Gupta A, Prajapati SK, Balamurugan M, Singh M, Bhatia D. Design and development of a proniosomal transdermal drug delivery system for Captopril. Trop J Pharma Res. 2007; 6: 687-693. http://dx.doi.org/10.4314/tjpr.v6i2.14647
13. Bachhav YG, Patravale VB. Microemulsion-based vaginal gel of sertraline: Formulation, in vitro evaluation, and stability studies. AAPS PharmSciTech. 2009; 10: 476-481. http://dx.doi.org/10.1208/s12249-009-9233-2
14. Jain S, Jain N, Bhadra D, Tiwary AK, Jain NK. Transdermal delivery of an analgesic agent using elastic liposomes: Preparation, characterization and performance evaluation. Curr Drug Deliv. 2005; 2: 222-233. http://dx.doi.org/10.2174/1567201054368020
15. Ammar HO, Ghorab M, El-Nahhas SA, Higazy IM. Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm. 2011; 405: 142-152. http://dx.doi:10.1016/j.ijpharm.2010.11.003
16. Bhowmik M, Sanchita D, Chattopadhyay D, Ghosh LK. Study of thermo-sensitive in-situ gels for ocular delivery. Sci Pharm. 2011; 79: 351-358. http://dx.doi.org/10.3797/scipharm.1010-04
17. Schreier H, Bouwstra JA. Liposomes and niosomes as topical drug carriers: Dermal and transdermal drug delivery. J Control Release. 1994; 30: 1-15. http://dx.doi.org/10.1016/0168-3659(94)90039-6
18. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes- novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000; 65: 403-418. http://dx.doi.org/10.1016/S0168-3659(99)00222-9
19. Lichtenberg D, Robson RJ, Dennis EA. Solublization of phospholipids by detergents: structural and kinetic aspects. Biochim Biophys Acta. 1983; 737: 285-304. http://dx.doi.org/10.1016/0304-4157(83)90004-7
20. Lasch J, Laub P, Woblrab W. How deep do intact liposomes penetrate into human skin? J Control Release. 1991; 18: 55-58. http://dx.doi.org/10.1016/0168-3659(92)90211-9
21. Lopez C, Maza A, Coderch L, Lopez Iglesia C, Wehrli E, Parra JL. Direct formation of mixed micelle in the solublization of phospholipid liposomes by Triton X-100. FEBS Lett. 1998; 426: 314-318. http://dx.doi.org/10.1016/S0014-5793(98)00363-9
22. Kirajavainen M, Monkkonen J, Saukkasaari M, Valjakka-Koskela R, Kiesvaara J. Phospholipids affects stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. J Control Release. 1999; 58: 207-214. http://dx.doi.org/10.1016/S0168-3659(98)00152-7